Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Fennec Pharmaceuticals Ownership Summary

Fennec Pharmaceuticals is owned by 15.27% institutional investors, 16.23% insiders, and 68.50% retail investors. Southpoint capital advisors lp is the largest institutional shareholder, holding 14.90% of FENC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Fennec Pharmaceuticals	15.27%	16.23%	68.50%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Southpoint capital advisors lp	4.08M	14.90%	$25.77M
Sonic gp	2.41M	8.80%	$15.21M
Solas capital management	2.25M	8.22%	$14.23M
Rosalind advisors	1.26M	4.60%	$7.96M
Blackrock funding, inc. /de	1.23M	4.48%	$7.75M
Blackrock	1.19M	4.39%	$7.25M
Dg capital management	1.11M	4.07%	$7.04M
Vanguard group	969.75K	3.54%	$6.13M
Harbert fund advisors	466.87K	1.71%	$2.95M
State street	339.71K	1.24%	$2.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sonic gp	2.41M	33.54%	$15.21M
Solas capital management	2.25M	9.45%	$14.23M
Lion point capital, lp	195.70K	6.48%	$1.24M
Rosalind advisors	1.26M	4.07%	$7.96M
Dg capital management	1.11M	2.37%	$7.04M
Harbert fund advisors	466.87K	1.53%	$2.95M
Southpoint capital advisors lp	4.08M	0.60%	$25.77M
Clayton partners	40.54K	0.18%	$256.21K
Hartford financial management	49.85K	0.06%	$315.04K
Sherbrooke park advisers	21.69K	0.04%	$137.07K

Top Buyers

Holder	Shares	% Assets	Change
Rosalind advisors	1.26M	4.07%	1.26M
Solas capital management	2.25M	9.45%	327.38K
Blackrock	1.19M	0.00%	259.78K
Clayton partners	40.54K	0.18%	40.54K
Morgan stanley	102.08K	-	28.00K

Top Sellers

Holder	Shares	% Assets	Change
Aigh capital management	-	-	-570.33K
Dg capital management	1.11M	2.37%	-407.51K
Essex investment management	-	-	-144.22K
Renaissance	-	-	-139.90K
Vanguard group	969.75K	0.00%	-78.14K

New Positions

Holder	Shares	% Assets	Change	Value
Rosalind advisors	1.26M	4.07%	1.26M	$7.96M
Clayton partners	40.54K	0.18%	40.54K	$256.21K
Susquehanna group, llp	12.43K	-	12.43K	$78.57K
Intech investment management	10.99K	0.00%	10.99K	$69.44K
Eversource wealth advisors	692.00	0.00%	692.00	$4.37K

Sold Out

Holder	Change
Newedge advisors	-1.00
Nelson, van denburg & campbell wealth management group	-3.00
Capital performance advisors llp	-5.00
Toronto dominion bank	-25.00
Citadel advisors	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	31	-50.00%	4,180,599	-72.00%	15	0.51%	23	-30.30%	4	-73.33%
Sep 30, 2024	62	-	14,931,284	3.97%	54	1.93%	33	-19.51%	15	36.36%
Jun 30, 2024	62	-7.46%	14,360,529	-0.88%	53	1.82%	41	13.89%	11	-42.11%
Mar 31, 2024	67	15.52%	14,487,913	-3.48%	53	1.68%	36	24.14%	19	35.71%
Dec 31, 2023	58	-1.69%	15,010,968	4.85%	56	1.94%	29	45.00%	14	-17.65%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	882.05K	3.20%	5.84K
Vanguard Total Stock Mkt Idx Inv	793.42K	2.88%	-
iShares Russell 2000 ETF	606.72K	2.20%	-5.28K
Fidelity Small Cap Index	237.00K	0.86%	-4.44K
iShares Russell 2000 Value ETF	159.35K	0.58%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	122.70K	0.44%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	122.70K	0.44%	-
Vanguard Russell 2000 ETF	110.00K	0.40%	2.50K
State St Russell Sm Cap® Indx SL Cl I	69.00K	0.25%	-
Schwab Small Cap Index	61.15K	0.22%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 04, 2025	Raykov Rosty	-	Sell	$52.50K
Mar 05, 2025	Raykov Rosty	-	Sell	$67.90K
Feb 14, 2025	RALLIS CHRIS A	-	Sell	$8.09K
Feb 05, 2025	Raykov Rosty	-	Sell	$66.60K
Jan 06, 2025	Raykov Rosty	-	Sell	$46.02K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2024 Q4	-	1
2024 Q3	-	4
2024 Q2	2	18
2024 Q1	-	5

FENC Ownership FAQ

Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 15.27%, followed by 16.23% insiders and 68.50% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Fennec Pharmaceuticals falls below.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Southpoint capital advisors lp (4.08M shares, 14.90%), Sonic gp (2.41M shares, 8.80%), and Solas capital management (2.25M shares, 8.22%). Together, they hold 31.92% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 33.54% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 15.21M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 882.05K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools